Fulgent Genetics Executive Activity and Recent Corporate Developments
The Chief Scientific Officer of Fulgent Genetics, Inc. (NASDAQ:FLGT), sold a portion of his holdings to cover tax obligations. The company recently reported first-quarter 2026 results that missed analyst expectations on both earnings per share and revenue. Despite these setbacks, FLGT announced strategic collaborations and provided interim data for…